Category Archives: Physiology

How do body parts grow to their right sizes? – The Week Magazine

Sign Up for

Our free email newsletters

Living things just seem to know how big to grow and how big to grow their sundry parts. A human liver maintains itself at just the right volume to do its job. A fruit fly's wings, on opposite sides of its body, somehow wind up the same size as each other, correctly scaled to sustain flight.

In everyday life, we expect body parts to be in proportion, because they usually are. "You notice if somebody comes up in front of you and one leg is way bigger than the other," says Ben Stanger, a gastroenterologist and researcher at the University of Pennsylvania's Perelman School of Medicine, who has studied organ growth.

But as much as we take this basic aspect of life on Earth for granted, scientists don't fully understand it. How do body parts know when to start and stop growing?

In some cases, cells seem to follow an intrinsic program carried out by the activity of their genes. At other times, cells appear to react to a cacophony of messages they receive from other cells and their environment, turning growth on and off as needed.

A lot of times, they seem to do a little of both. And when they're cancer cells, the whole business has gone awry.

"We don't get it," says Stanger, author of a 2015 article in the Annual Review of Physiology that described mechanisms that control liver growth.

Starting with salamanders

Scientists have been trying to "get it" for a long time. In the 1930s, Yale zoologists Victor Twitty and Joseph Schwind conducted experiments in salamanders, cross-transplanting limb buds from a smaller species, Ambystoma punctatum, with those of a larger but closely related species, Ambystoma tigrinium. In some experiments, the researchers found that taking a limb bud from the small salamander and grafting it onto the larger salamander resulted in an animal with three large limbs and one small one (and vice versa). This suggests that "the information for size was embedded in that group of cells very early on and didn't care what was happening in the animal," Stanger says.

But Twitty and Schwind found in other experiments that nutrition an external regulator also affected limb size. "It's nature and it's nurture," Stanger says. "In biology, it's never either/or."

Developmental biologists soon discovered a variety of ways that organs and structures achieve their ultimate sizes. In one famous 1960s experiment, researcher Donald Metcalf implanted 6 or 12 fetal mouse spleens into individual adult mice whose own spleens had been removed. He found that each implanted spleen grew to a proportional fraction of the size of a normal adult spleen leaving the animal with a normal total amount of spleen material. This suggests that spleen tissue has a way of understanding how much of it there is in relation to the body, says Jamie Davies, an experimental anatomist at the University of Edinburgh in Scotland. But "really annoyingly," Davies says Metcalf also found that multiple thymus grafts implanted in an adult mouse behave completely differently: Each grows to its full adult size.

Decades later, Stanger found similar growth differences in the mouse liver and pancreas: Cells that give rise to the liver use environmental cues to determine how much the developing organ should grow, while those that form the pancreas follow an "autonomous trajectory" they always achieve a preprogrammed size, no matter what is going on around them.

Pumping the brakes on growth

Scientists have sussed out a reasonable amount of detail about some of the feedback-based programs that direct growth. A protein called myostatin, for instance, helps to suppress muscle growth. When the tissues get large enough to pump out a threshold amount, muscle cells stop growing. The molecular processes that dynamically regulate liver size seem to involve tissues in the gut: When levels of bile acid fall (a sign of reduced liver function), those gut tissues produce factors that disengage a brake on liver growth known as the Hippo pathway. As a result, growth kicks into gear allowing the liver to grow to its proper size. When bile acid levels rise to normal, Hippo comes back on, and liver growth turns off again. And so on.

The Hippo pathway is a super-popular subject of study today, both because of its job in regulating organ size and because of its potential role in controlling cancers. Many questions about it remain unanswered.

Mysteries also remain for cases where instructions for size are baked in, as seen in those early experiments with salamander limbs, says Laura Johnston, a geneticist and developmental biologist at Columbia University Medical Center. Labs are delving into a number of inputs that may play a role in directing cells to grow, from information about cell fates and cell organization that are hardwired in the DNA, to mechanical forces on tissues.

Johnston's own research, some of which she and her coauthors described in a 2009 article in the Annual Review of Cell and Developmental Biology, focuses on a phenomenon known as cell competition interactions that lead to the deaths of unfit or unneeded cells. It seems to play a role in stabilizing organ size. When researchers in her lab blocked cell-death mechanisms in the cells that give rise to fruit fly wings, they found that the bell-curve-shaped distribution of wing sizes normally seen in fly populations broke down. A larger-than-usual number of flies developed overly large wings, or overly small ones. It's as if, she says, "the precision of size regulation is lost if the cells can't do these competing interactions."

There's still much to learn out about the deceptively simple, fundamental questions of how an arm matches its corresponding limb or how a liver ends up just the needed size. But the questions have practical ramifications too. Many growth studies today, including myriad explorations of the Hippo pathway, are conducted in the service of understanding and treating cancers. "Researchers are saying, 'Look cancer is development gone wrong, and it's obviously growth-connected, so we really need to understand growth on its own,'" Davies says.

Also interested in organ growth are researchers who want to engineer tissues using stem cells. "There's always the worry that if you build something that will grow up inside the body," Davies says, "will it know when to stop?"

This article originally appeared in Knowable Magazine, an independent journalistic endeavor from Annual Reviews. Sign up for the newsletter.

Continue reading here:
How do body parts grow to their right sizes? - The Week Magazine

The Anatomy Chronicles: Art, science and the body – Etownian

Photo by: Maddie Kauffmann

Anatomy, many would argue, is one of the trickiest subjects to learn.

Its hard enough to understand the split-second processes that your body undertakes to keep you alive, and its even harder when you cant visualize any of the crucial organs that carry them out.

Its a challenge of which associate professor of biology Anya Goldina is well aware. In comes the project The Anatomy Chronicles.

Each year, students in Goldinas Biology 201 and 202 Anatomy and Physiology classes are offered the opportunity to earn extra credit by making a creative piece that explains or highlights a part of the body.

This years exhibit includes poems, childrens books and cartoons, among other creations.

So why look at anatomy through a creative lens rather than its typical science-oriented one?

According to the events description, its a critical oversight to not consider how the topic lends itself to artistic endeavors.

Human Anatomy and Physiology is part of our lives. It is what allows us to innovate, achieve incredible feats of athleticism and grace, climb mountains, dive oceans, fly into space and create the works shown in this exhibit, the description said.

Its a sentiment shared by Goldinas students.

Many people try to divide the sciences and the arts, which I think is a mistake, Sophomore Casey Nathan said of the exhibit. The integration of the two subjects helps us deepen our understanding of our own bodies while providing a creative outlet for the information learned in the class.

For Nathans own project, she made a drawing of the brain completely out of word art, curving and stretching the letters of each word to represent their meaning and how they contribute to the shape of the brain.

It helps me conceptualize what the different parts of the brain look like, and Im finding it helps me remember how it all fits together too, because I remember how I tried to make all of the words sit inside the shape of the brain. I went through like 10 pieces of paper, she laughed.

The value of The Anatomy Chronicles doesnt just include the ability to combine science and art.

The exhibit, and its construction, also help students understand the course material on a different level.

It becomes easier for us to understand, not just because of the time we put into researching and creating the projects, but we get to see the systems through the eyes of our peers who break it down into parts that are easier to understand, sophomore Michaela Teague said. It also allows us the opportunity for a grade boost in a way that everyone feels like theyve really earned, she continued.

Sophomore Katlyn Harper agreed.

The most important part of this exhibit has probably honestly been just seeing everyone elses projects and seeing all new insights because of the way they structured their stories or pictures, she said.

New insights seem to be the key, especially when dealing with concepts that can sometimes feel monotonous.

It really helps all of the concepts resonate in a way that feels new and fresh. As an Occupational Therapy major, I took classes in high school in preparation for my classes here at Etown. So when I got into Anatomy this year I kind of felt like a lot of the concepts were things I had already learned, Harper said. But this project allowed me to see a lot of things I thought I knew from a new perspective.

The project isnt just valuable to Anatomy students, however.

Nathan encourages everyone to come check out the exhibit.

You dont need to be a biology, or a chemistry, or an OT major to enjoy the exhibit. Everyone should want to know whats going on in their body. And its fun! It takes an abstract concept and makes it tangible. And isnt that what learnings all about? Nathan said.

The Anatomy Chronicles will be on display in the Winters Alcove of the High Library until the end of this month.

Read the rest here:
The Anatomy Chronicles: Art, science and the body - Etownian

When is the best time to take blood pressure meds? – Clinton Herald

DEAR DR. ROACH: I read on the internet that you should take your blood pressure medicine at night. I just recently started taking medicine for my blood pressure and my instructions were to take it first thing in the morning. So, when is the best time to take it? B.H.

ANSWER: A study published last October showed that, as a group, people who were told to take all their high blood pressure medicines at night had surprisingly fewer bad events (heart attack, heart failure, stroke, procedure to open heart blood vessels or death due to cardiovascular causes) than people who were told to take their medicines in the morning. Subjects in the study could be taking any of the major types of blood pressure medicines that are normally given once daily.

The reason those who took their medicines at night did so much better may be related to normal physiology. During sleep, the blood pressure normally dips down. In some people, there is a diminished dip or even the opposite occurs a rise in blood pressure. Taking blood pressure medicine at nighttime restored or enhanced the normal response. In addition, blood pressure normally rises around 6:00 in the morning, timed with an increase in the blood levels of the hormone cortisol. This is the peak time for heart attacks. Its possible that having protection from high blood pressure at this time from taking it at night could help prevent heart attacks. Thats opposed to those taking it during the day; at 6 a.m., the medicine is wearing off and protection is at its lowest.

The findings in the study are dramatic. There was a 45% relative risk reduction in the number of people who had any of the bad outcomes studied. This translates to about 1 person in 18 over the six years of the study not getting an event, or an absolute risk reduction of just over 5%.

Some of my colleagues have already started telling their patients to change the time they take their blood pressure medicines to nighttime. I would caution against doing so without talking to your doctor. I would also add that taking diuretics at bedtime can cause some people to have to get up during the night.

DEAR DR. ROACH: I had a skin blemish removed by burning at a dermatologist office. One wouldnt seem to heal and a follow-up to the dermatologist with a biopsy found it to be a keratoacanthoma. I am not scheduled for a return visit as there was treatment during the time of the biopsy. What is the prognosis for this type of condition? A.A.

ANSWER: Experts argue whether keratoacanthoma is a benign tumor (which can sometimes go away by itself) or a skin cancer that can rarely spread to other locations. However, since it can be difficult or impossible to tell the difference between keratoacanthoma and squamous cell cancer of the skin, I think surgical removal is the most appropriate treatment. If the tumor was completely removed during biopsy, then your prognosis is excellent. However, 3% to 8% of keratoacanthomas recur after biopsy. You should definitely see your dermatologist immediately if you see signs of regrowth at the site of biopsy.

Otherwise, I would recommend a return visit to the dermatologist in six months for a complete skin exam as well as to let the dermatologist look at the biopsy site.

Read the original post:
When is the best time to take blood pressure meds? - Clinton Herald

Valentine’s Day Matters of the Heart, Biopharma-Style – PharmaLive

On Valentines Day, BioSpace would be remiss not to mention, er, matters of the heart. There are reportedly 59 life sciences companies or organizations worldwide that focus on the cardiovascular system, ranging from the Aab Cardiovascular Research Institute based in West Henrietta, New York to XyloCor Therapeutics, headquartered in Philadelphia, Pennsylvania. That number is probably low.

But no matter how you look at it, there is a significant amount of work being done on cardiovascular diseases. Heres a look at just some of the recent news.

On January 28, 2020, the U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Companys Trijardy XR for lowering blood sugar in adults with type 2 diabetes.

Trijardy XR is a triple-combination pill that includes Jardiance (empagliflozin), Tradjenta (linagliptin) and metformin hydrochloride extended release. It is prescribed along with diet and exercise for decreasing blood glucose levels in type 2 diabetes.

In the U.S., Jardiance and Radjenta are once-daily tablet used to treat adults with type 2 diabetes. Jardiance has also been approved to decrease the risk of cardiovascular death in adults with type 2 diabetes with known cardiovascular disease.

On February 3, 2020, researchers with the University of South Florida (USF Health) identified key mechanisms behind the loss of capillaries, which drives numerous diseases, including high blood pressure, diabetes, malignant cancer and a variety of cardiovascular and neurodegenerative diseases.

Capillary regression (loss) is an underappreciated, yet profound, feature of many diseases, especially those affecting organs requiring a lot of oxygen to work properly, said George Davis, professor of molecular pharmacology and physiology at the USF Morsani College of Medicine in Tampa, Florida. If we know how blood vessels are altered or begin to break down, we should be able to fix it pharmacologically.

Davis led a research project that identified the three major proinflammatory mediators that drive capillary loss. They published the research in the journal Arteriosclerosis, Thrombosis, and Vascular Biology.

The mediators are interleukin-1 beta (IL-1), tumor necrosis factor alpha (TNFalpha) and thrombin). They found that individually and even more so when combined, these directly drive capillary regression. They also identified drug combinations that can neutralize antibodies that specifically block IL-1 and TNFalpha, that can interfere with this capillary loss.

On January 27, 2020, AstraZeneca announced that its Brilinta (ticagrelor) hit the primary endpoint in the Phase III THALES trial in stroke. The study showed that 90mg of Brilinta twice a day and taken with aspirin for 30 days, provided a statistically significant and clinically meaningful decrease in the risk of stroke and death compared to aspirin alone. The trial was run in more than 11,000 patients who had a minor acute ischemic stroke or high-risk transient ischemic attack (TIA) in 24 hours before the beginning of treatment.

Results of the Phase III THALES trial showed Brilinta, in combination with aspirin, improved outcomes in patients who had experienced a minor acute ischemic stroke or high-risk transient ischemic attack, said Mene Pangalos, executive vice president, BioPharmaceuticals R&D. We look forward to sharing the detailed result with health authorities.

Earlier that month, however, the company announced that after a recommendation from an independent Data Monitoring Committee, it was abandoning its Phase III STRENGTH trial for Epanova (omega-3 carboxylic acids) for mixed dyslipidemia (MDL). Epanova is a fish oil-derived combination of free fatty acids composed mostly of EPA and DHA. It was approved in the U.S. as an adjunct to diet to decrease triglyceride levels in adults with severe high triglycerides. That indication wasnt changed by the data from the STRENGTH trial.

AstraZenecas exit from the fish oil drug trial largely leaves Amarin Corporations Vascepa (icosapent ethyl) as the only fish-oil drug to not only treat high triglycerides, but to decrease the risk of first and subsequent heart attacks, strokes and heart problems. In its clinical trials, Vascepa decrease those risks by 30%.

Although derived from fish, Vascepa is not fish oil. It is made up of the omega-3 acid (EPA) in ethyl-ester form. It was designated a new chemical entity by the FDA,

The same day AstraZeneca made their announcement, another company in the market space, Acasti Pharma, also reported a failure. Its own fish oil-based candidate, CaPre (omega-3 phospholipid) for severe hypertriglyceridemia, announced topline data from its Phase III TRILOGY 1 trial. Although it reported a 30.5% median reduction in triglyceride levels compared to 27.5% in the placebo group at 12 weeks, as well as a 42.2% decrease in patients on background statins compared to 31.5%, because of an unexpectedly large placebo response, the trial did not reach statistical significance.

And as long as were belaboring the Matters of the Heart theme, in mid-December 2019, Vancouver, British Columbia-based Novoheart signed an exclusive licensing deal with Harvard Universitys Office of Technology Development.

The deal allows Novoheart to merge its MyHeart Platform with Harvards tissue-engineered scale model of the heart ventricle and bioreactor technology. Novoheart invented and commercialized the first and only human heart-in-a-jar model for drug discovery and development.

Harvards valved bioreactor technology was engineered in Kevin Kit Parkers laboratory. He is the Tarr Family Professor of Bioengineering and Applied Physics at Harvard A. Paulson School of Engineering and Applied Sciences.

The two institutions expect that the merged technology will result in a next-generation human heart-in-a-jar that will be a superior human heart model for disease modeling, drug discovery and development with unmatched biofidelity as well as significantly enhanced predictive accuracy, capacity and versatility.

In addition to developing various bioengineered human heart constructs, Novoheart wants to develop the technology into transplantable grafts for cell-based regenerative heart therapies. The companys various products include Human Ventricular Cardiomyocytes (hvCM), Cardiac Anisotropic Sheet (hvCAS), Cardiac Tissue Strip (hvCTS), and Cardiac Organoid Chamber (hvCOC). It also offers consultation and screening and phenotyping services using its 2D or 3D tissue assays.

On November 26, Novoheart announced a collaboration with AstraZeneca to develop the worlds first human-specific in vitro, functional model of heart failure with preserved ejection fraction (HFpEF). Working with AstraZenecas Cardiovascular, Renal and Metabolism team, they will initially establish a new in vitro model using Novohearts proprietary 3D human ventricular cardiac organoid chamber (hvCOC), also known as the human heart-in-a-jar.

Overall, we dont recommend buying your sweetheart a heart in a jar. Go with the classicschocolates or flowers, instead.

BioSpace source:

https://www.biospace.com/article/valentine-s-day-matters-of-the-heart-biopharma-style

Read more from the original source:
Valentine's Day Matters of the Heart, Biopharma-Style - PharmaLive

Independent experts publish open letter challenging AAAS on failure to accept academic responses revealing key flaws in Science Magazine article…

MILANO, Italy, Feb. 14, 2020 /PRNewswire/ -- An Open Letter to AAAS Science Magazine from members of the SeTA (Science and Technology for Agriculture, http://www.setanet.it) network.

In a recent letter to Science, Peng et al. (2020) argue that the USA and the European Union (EU) should enact a total ban on glyphosate on the grounds that it causes "a cascade of neuro-endocrine disruption to the development, physiology, and behaviour of honeybees" and that "some evidence has indicated that glyphosate could promote (sic) cancer in humans." Consequently, they call for "natural and ecological weedkilling alternatives and less intensive farming practices."

The authors cherry-pick references, some of them being second-handed (e.g.: # 1, 3, 8, 9, 10), to support their statements, and pay little attention to the need of making assessments under real-life conditions of exposure of both humans and wild-life. The few original scientific papers that are quoted (# 4, 5, 6) have little indication that the experimental conditions resemble real life wild animals exposure and have not been independently replicated.

There is an almost complete consensus by the governmental regulatory bodies in the world (see e.g. EPA, EChA, EFSA, FAO/WHO JMPR) that glyphosate does not harm human health. Only IARC (2015) concluded that glyphosate is probably carcinogenic to humans while EPA warned against labelling glyphosate containing products as carcinogenic (EPA 2019). Hence, there is no ground to call for a ban of glyphosate because of its carcinogenicity despite a vocal media campaign in this respect, which should not be part of a scientific debate; see their reference #8 which is from an activists' association. Unless we want, as their reference #1 proposes, that regulatory decisions are based on ordeal rather than science.

In conclusion, the call for the ban of glyphosate is unsubstantiated because its use appears safe for humans and wildlife if applied appropriately according to the approved indication. Moreover, its ban will have both economic and environmental negative consequences to agriculture, including the possibility of either abandonment of conservation agriculture, a practice strongly promoted worldwide to improve soil and water quality, or the application of less effective and more expensive chemical and non-chemical means. Other approaches suggested by Peng et al., such as "root exudates, crop rotation, mulch, herbicidal soaps, fatty acids, and industrial vinegar" looks like morewishful thinking than a real alternative, as indeed suggested by their reference #11.

As side notes we would like to point out that Peng et al. confuse herbicides such asglyphosate with insecticides such as DDT and parathion which, acting on the nervous system, under uncontrolled exposures cause harm to humans. Therefore, glyphosate cannot be an "alternative" to DDT and parathion as stated. Moreover, reference #11 is misreported, since the first, and not the last, names of the authors are given, and reference #3 is misquoted since it does not report on human toxicity of either glyphosate or insecticides; rather, it hints that glyphosate may be more ecologically sustainable than its alternatives, a correct statement for us.

Angelo Moretto, Department of Biomedical and Clinical Sciences , Universit degli Studi di Milano and International Centre for Pesticides and Health Risks Prevention, Luigi Sacco Hospital, Milano, Italy

Vittoria Brambilla, Department of Agricultural and Environmental Sciences, Universit degli Studi di Milano, Italy

Roberto Defez, IBBR-CNR, Napoli, Italy

Aldo Ferrero, Department of Agricultural, Forest and Food Sciences, Universit degli Studi di Torino, Italy

Donatello Sandroni, Giornalismo & Comunicazione, Crotta d'Adda (CR), Italy

All authors are member of the SeTA (Science and Technology for Agriculture, http://www.setanet.it) network.

NOTE: A shorter version of this letter was rejected by Science editor who did not provide us with an explanation. It was also sent to Nature but there was no answer after the acknowledgment. The full text with footnotes and references of this letter is available at: https://science20.org/angelo-moretto/20200213/open-letter-aaas-science-magazine-science-and-technology-agriculture

View original content:http://www.prnewswire.com/news-releases/independent-experts-publish-open-letter-challenging-aaas-on-failure-to-accept-academic-responses-revealing-key-flaws-in-science-magazine-article-supporting-glyphosate-ban-in-europe-and-the-united-states-301005441.html

SOURCE SeTA

Read the original post:
Independent experts publish open letter challenging AAAS on failure to accept academic responses revealing key flaws in Science Magazine article...

Arthur Michalek Receives Tenure and Promotion to Associate Professor at Clarkson University – Clarkson University News

Professor Arthur Michalek

Clarkson University President Tony Collins has announced that Arthur Michalek has been granted tenure and promoted from assistant professor to associate professor of mechanical and aeronautical engineering in the Wallace H. Coulter School of Engineering.

Professor Michalek's research focuses on biomechanics of low back pain, with a particular focus on injury and repair of the intervertebral disc. This soft connective tissue structure is responsible for the dual roles of maintaining stability and connectivity of the spinal column while also allowing it to bend. The disc is composed of a complex, hierarchical fiber reinforced composite, which is extremely strong but slow to heal from injuries.

Current areas of investigation include growth and development of fibrous tissue structures, the mechanical consequences of tissue damage at a broad range of size scales, and evaluation of clinical therapeutic procedures with an eye towards minimizing invasiveness. This is accomplished through integration of mechanical testing, advanced digital imaging and analysis, and analytical modeling.

He received his bachelor of science and master of science degrees in mechanical engineering from Clarkson and his Ph.D. in mechanical engineering from the University of Vermont.

Before coming to Clarkson, Michalek was a post-doctoral research fellow in the Department of Molecular Physiology & Biophysics at the University of Vermont, where he worked to develop experimental techniques to relate post-translational modifications to changes in conformational and mechanical properties of single molecules. Prior to that, he was a post-doctoral research associate at UVM's School of Engineering.

Read more:
Arthur Michalek Receives Tenure and Promotion to Associate Professor at Clarkson University - Clarkson University News

Pulitzer-winning Jared Diamond calls on young Japanese to take action on env. issues – The Mainichi

Jared Diamond, professor of biology at the University of California, speaks with the Mainichi Shimbun during a Dec. 13, 2019 interview in Tokyo's Chiyoda Ward. (Mainichi/Kota Yoshida)

TOKYO -- In a call-out to Japanese people, American geographer Jared Diamond said, "Tell them (older people and people in power) when they're doing stupid things, such as investing in coal-fired plants and having a national pension firm that is investing in coal-fired industries."

University of California professor of geography Diamond is the author of the Pulitzer Prize-winning "Guns, Germs, and Steel". In his books, he looks into the causes of environmental problems based on his theories of human civilization and organization, raising questions about the state of civilization which people should strive for.

The 82-year-old held a press conference in Japan last December as a recipient of the 28th Blue Planet Prize, which is given to people whose work has contributed significantly to the improvement of the global environment. There, he encouraged young people in Japan, which he described as a "country in the developed world most sensitive to the effects of climate change," to vote, discuss and voice their opinions.

Born in the United States, Diamond earned a doctoral degree in physiology at Britain's University of Cambridge. After graduating, he conducted research on the human gallbladder back in the U.S. while also carrying out field research on birds in New Guinea.

The birth of his twin sons in 1987 had a great impact on his carrier path. He recalled thinking, "I will be dead in 2050 because I was born in 1937, but my sons will be at the peak of their lives in the year 2050. And their lives are going to be determined by the state of their environment."

Diamond told a Mainichi Shimbun reporter that he was especially concerned about the risks of climate change, depletion of quality resources and the risks of a nuclear war. He added, "And so at the age of 50, I began a career shift to writing books about the effect of geography and history on the lives of people."

During the interview, Diamond sharply criticized Japan's dependence on overseas natural resources and coal-fired power plants, as well as Tokyo's measures against climate change.

When asked what Japan needs to do to solve environmental issues, he explained, "Political will throughout the world is necessary to reduce energy consumption and to shift more of our energy to renewable sources. For example, for Japanese banks to stop investing in coal-fired plants."

(Japanese original by Ai Oba, Science & Environment News Department)

See the article here:
Pulitzer-winning Jared Diamond calls on young Japanese to take action on env. issues - The Mainichi

Allowing arts, commerce students in B Sc Nursing will lower quality: Nurses associations – The News Minute

Indian Nursing Councils recent proposal calls for allowing students from arts, humanities or commerce backgrounds to be eligible for the four-year B Sc Nursing course.

The recent proposal of the Indian Nursing Council (INC) to open B Sc Nursing course for students from non-science backgrounds has met with strong opposition from nurses and nursing students associations in the country.

It was recently that the Indian Nursing Council put out a proposal which states that the students who studied in arts, humanities or commerce background in class 12 can also apply for the four-year B Sc Nursing course, just like the science students.However, many say that this will adversely impact the quality of education, and the nurses who pass out of the courses.

The Indian Nursing Council, after publishing the draft proposal had given time from the stakeholders to raise their feedback about it till January 24, and the associations say that many have stated their objections.

There is widespread resentment among the nursing community against this proposal, so we hope they take it back or else, we will be forced to take streets against the move, said Dr Sona PS, Kerala state President of Trained Nurses Association of India.

Against eligibility of non-science students

Indian Nursing Council says that B Sc Nursing will be a four-year full-time program comprising eight semesters, which prepares a student to become a registered nurse qualified to practice in a variety of settings in either government or private healthcare settings. The proposal states that candidates with Science/Arts/Humanities/Commerce who have passed the 12th Standard examination (10+2) and have obtained a minimum of 45% marks in the core/elective/academic subjects taken together and passed English individually are eligible.

But what are the students going to learn if they do not possess the basic understanding about human anatomy and physiology which they learn during class 11 and 12? This proposal, if it comes into force will lower the standards of the nurses that pass out from the country. Even to get admission for a paramedical course, the student needs to have a science background. How can a professional nursing course, which requires an aptitude for the profession, allow a student coming from non-science background? Dr D Manivannan, Tamil Nadu state secretary of Trained Nurses Association of India, questioned.

It is not just the nursing professionals who are opposing the proposal. Students point out that it's not feasible too, given that first year students will likely have to study, among other subjects, human anatomy, physiology, biochemistry and microbiology.

Even the students coming from science background struggle to clear these papers. We dont understand what a student of humanities or commerce is going to do without even knowing the basics of these subjects, said Arjun BP, Vice-President of Student Nurses Associations Kerala chapter.

There are also some issues with the structure of the course. Arjun adds that the semester system that will replace the yearly system - will make it more difficult for students to cover their already tough syllabus. And Dr Sona points out that the new proposal has made the teacher-student ratio from one teacher for 10students to one teacher per 15 students.

Might be to attract more students

The Indian Nursing Council had in 2019 decided to stop the diploma course in General Nursing and Midwifery (GNM) from 2021. According to experts, this diploma course was a popular nursing course because it cost less than B Sc Nursing. In some states, GNM was offered for students from non-science backgrounds also.

In the case of Kerala, at present, there is no shortage of students for B Sc Nursing -- the demand is in surplus in fact. But that is not the situation in many states in north India. So, we think this proposal of the Council to start the degree course for students of all streams is aimed to increase the student flow to B Sc, Dr Sona said.

She added that though many non-science students used to opt for GNM course, when they come to practice in Kerala, they will have to clear an exam of the Kerala Nursing Council, which most of them fail to.

Backlash for brand name Kerala nurses

Kerala is one of the best states in the country in terms of healthcare facilities, and is known for its nursing community abroad as well. With the proposed criteria for entry to B Sc Nursing, it is feared that the quality nurses passing out will reduce, eventually reducing demand of nurses from Kerala.

The nursing community from Kerala has a special reputation globally compared to nurses from other states in India. That is because of the quality of the professionals passing out from the state. But if this proposal allowing non-science students to study the course comes into effect, it will tarnish the image internationally. It will also impact the brand name of nursing communities from Kerala, said Aneesh D, staff advisor of Kerala chapter of Students Nursing Association.

Here is the original post:
Allowing arts, commerce students in B Sc Nursing will lower quality: Nurses associations - The News Minute

Circadian rhythms in the absence of the clock gene Bmal1 – Science Magazine

Redundancy in circadian clocks?

The transcription factor BMAL1 is a core component of the mammalian circadian clock; without it, circadian behaviors are abolished. However, Ray et al. found that in animals lacking BMAL1, peripheral tissues synchronized with a brief pulse of the glucocorticoid hormone dexamethasone appear to retain a 24-hour pacemaker that sustains rhythmic gene expression, protein abundance, and protein phosphorylation in excised liver cells and fibroblasts (see the Perspective by Brown and Sato). These oscillations persisted in the absence of cues from changes in light or temperature. The results raise intriguing questions about the possible nature of the oscillator that maintains the observed rhythms.

Science, this issue p. 800; see also p. 740

Circadian (~24 hour) clocks have a fundamental role in regulating daily physiology. The transcription factor BMAL1 is a principal driver of a molecular clock in mammals. Bmal1 deletion abolishes 24-hour activity patterning, one measure of clock output. We determined whether Bmal1 function is necessary for daily molecular oscillations in skin fibroblasts and liver slices. Unexpectedly, in Bmal1 knockout mice, both tissues exhibited 24-hour oscillations of the transcriptome, proteome, and phosphoproteome over 2 to 3 days in the absence of any exogenous drivers such as daily light or temperature cycles. This demonstrates a competent 24-hour molecular pacemaker in Bmal1 knockouts. We suggest that such oscillations might be underpinned by transcriptional regulation by the recruitment of ETS family transcription factors, and nontranscriptionally by co-opting redox oscillations.

Read the original here:
Circadian rhythms in the absence of the clock gene Bmal1 - Science Magazine

UC Davis Mental Health Conference focuses on awareness and reducing stigma – The Aggie

The fourth annual conference hosted presentations by experts and students in a broad spectrum of fields

Students and Davis community members alike gathered to the UC Davis Conference Center on Jan. 25 to start off the fourth-annual Mental Health Conference. Inspired by the Reclaim Mental Health Conference hosted by UC Irvine, the UC Davis Mental Health Conference first began in 2016 as an entirely student-run ASUCD project and is the largest mental health conference in northern California. This year, the conference garnered international attention and had over 300 attendees.

The two-day conference is run by the mental health initiative with support from ASUCD though getting funding has not been easy, according to Deborah Widjaja, co-director of the Mental Health Initiative. Widjaja, who is also a fifth year neurology, physiology, and behavior major, attested to the efforts of the mental health initiative team members and board for organizing the event.

I personally have worked with many other organizations both in high school and my earlier years in college and Ive never worked with a team as compassionate and loving and dedicated as these folks who are fighting for a cause that is so highly stigmatized, Widjaja said.

The conference sought to raise awareness for various topics surrounding mental health as it becomes an ever prevalent issue in college students. According to a report by the American College Health Association, 41.9% of college students have felt so depressed that it was difficult to function and 63.4% have felt overwhelming anxiety in the past 12 months.

Opening keynote speaker Dailyn Santana, a Cuban American actress and mental health advocate, started off the conference with a spoken word poem. Her presentation focused on combating stigma as she spoke of her own experiences with bipolar disorder.

I remember my parents feeling personally responsible for my manic episode. They felt like they failed me as a parent, that it was all their fault, Santana said. But, the reality is, my illness had to finally make itself present in a way that I could finally get the diagnosis and help that I need.

The conference also featured 12 different speakers in four different 50-minute workshop sets with the option to choose between 3 speakers during each workshop.

Each workshop set featured a range of topics that touched upon different aspects of mental health, including police use of force and individuals with mental illness, harm reduction and music therapy. Second-year neurology, physiology, and behavior major Macy Mehdioun, who is also a team member of the UC Davis mental health initiative, said that this broad approach is crucial in gaining perspective on mental health issues.

We address mental health with people on the autism spectrum* or with immigration, so its trying to address different topics and the way mental health connects with everything, Mehdioun said. Just to learning something new and [to be] able to use what you learn from this conference in everyday life.

While a wide range of topics were covered, each speaker delved deep into their subject area. For instance, Dr. Laramie Taylor, who is also a UC Davis professor in the Department of Communication, began his presentation about the power of the media in influencing how one thinks about their body by introducing research data, building upon this to draw conclusions about how to improve mental wellness.

Student and professional panels were also run during the first day of the conference, providing attendees a chance to learn from industry specialists in counseling and emergency medicine. The day closed out with a one and a half hour Question Persuade Refer (QPR) session, which helps individuals identify the signs of suicide and how to respond in such a situation.

The city of Davis itself offers many different resources to support mental health wellness and awareness, and those were highlighted during the resource fair at the conference. Groups such as the Yolo County chapter of the National Alliance on Mental Illness (NAMI), an organization that educates and advocates for mental illness recovery, and the Postpartum Anxiety N Depression Advocates (PANDA), a student organized club at UC Davis that raises awareness about perinatal mood disorders were tabling at the event.

Attendees overall said that the conference shed light on some of the more important issues in mental health. First-year biochemistry and molecular biology major Jagnoor Randhawa found the event to be greatly beneficial in expanding in her awareness of mental health and ways of approaching the relating issues.

I feel like having a mental health conference is a great way to show awareness and also reduce stigma regarding mental health issues, Randhawa said. Due to mental health awareness, the chances for early intervention can increase, which can result in a fast recovery.

Co-director of the Mental Health Initiative Cindy Chen, who is also a fourth-year animal science major, says her hope is that the mental health conference leaves a lasting impact year after year on the people who attend.

The workshops and panels are equally important and its a place for people to share their stories, and it gives people the chance to see how each individual handles their situation differently, Chen said. I hope people keep [the stories] in mind and that gives them more ideas for how to spread mental health awareness in the future [] and that it kind of helps alleviate the stigma a little bit better, and that it can help keep the conversation going.

*The Alternative Treatments for Autism workshop was canceled and a Supporting People with Hoarding Challenges workshop was held instead.

Written by: Lei Otsuka features@theaggie.org

Go here to see the original:
UC Davis Mental Health Conference focuses on awareness and reducing stigma - The Aggie